Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORE
This episode focuses on some basic aspects of CAR-T cell therapy, such as types of CARs, costimulatory domains, gene transfer strategies, and current challenges.
Leukemia remains the leading cause of death from childhood cancer. This episode focuses on how CAR-T cell therapy brings hope to childhood leukemia patients.
This episode focuses on the clinical outcomes in adult leukemia patients treated with CAR-T cells, current challenges limiting the efficacy, and future research directions.
This episode focuses on various aspects of TCR-engineered T cell therapy, such as risks, clinical trials, and comparison between TCR engineered T cells and CAR-T cells.
This episode focuses on obstacles and corresponding strategies in allogeneic hematopoietic cell transplantation, and the progress in generating cytomegalovirus-specific T cells.
This episode focuses on the introduction to Epstein-Barr virus and Epstein-Barr virus-specific T cells, as well as advances in the development of multi-virus-specific T cells.
This episode focuses on advances in broadening the repertoire of available donor sources, including the generation of virus-specific T cells from virus-naïve individuals and the use of third-party donors.
This episode focuses on the application of regulatory T cells for the prevention and treatment of graft-versus-host disease.
This episode focuses on the regulatory T cell expansion as an attractive option to suppress the development of graft-versus-host disease.
This episode focuses on the mechanisms of immunosuppression by regulatory T cells, including direct and indirect mechanisms.
This episode focuses on the biology of natural killer (NK) cells and their function for application in tumor therapy.
This episode focuses on the approaches and current challenges in using natural killer cells as cancer immunotherapies.
This episode focuses on the understanding of natural killer cell function in healthy humans that has led to translational strategies for the treatment of cancer patients.
This episode focuses on the in-depth understanding of human dendritic cells and their role in the immune system.
This episode focuses on the application of human dendritic cells in clinical hematopoietic cell transplantation.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
